Filing Details

Accession Number:
0001179110-13-007932
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-07 19:01:17
Reporting Period:
2013-05-03
Filing Date:
2013-05-07
Accepted Time:
2013-05-07 19:01:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080014 Theravance Inc THRX Pharmaceutical Preparations (2834) 943265960
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1302445 L David Brinkley Theravance, Inc.
901 Gateway Boulevard
South San Francisco CA 94080
Head Of Business Dev. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-03 16,129 $29.65 71,129 No 4 M Direct
Common Stock Disposition 2013-05-03 16,129 $34.77 55,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-05-03 16,129 $0.00 16,129 $29.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-02-07 No 4 M Direct
Footnotes
  1. DISPOSITIONS MADE PURSUANT TO A PLAN INTENDED TO COMPLY WITH RULE 10b5-1(c).
  2. This transaction was executed in multiple trades at prices ranging from $34.65 to $34.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  3. Immediately exercisable.